| EMAIL: | PUBLICATIONS: |
| I leverage novel mouse models toward the elucidation of pathophysiological mechanisms underlying neurodevelopmental disorders, with the ultimate goal of developing efficacious gene therapies. Currently, I am preclinically testing a gene transfer therapy for Angelman syndrome and exploring opportunities to treat Dup15q syndrome with UBE3A-targeting antisense oligonucleotides. |
| AFFILIATIONS: | CATEGORIES: |